Shared IGHV1-69-encoded neutralizing antibodies contribute to the emergence of L452R substitution in SARS-CoV-2 variants

SARS-CoV-2 variants continue to emerge facing established herd immunity. L452R, previously featured in the Delta variant, quickly emerged in Omicron subvariants, including BA.4/BA.5, implying a continued selection pressure on this residue. The underlying links between spike mutations and their selective pressures remain incompletely understood. Here, by analyzing 221 structurally characterized antibodies, we found that IGHV1-69-encoded antibodies preferentially contact L452 using germline-encoded hydrophobic residues at the tip of HCDR2 loop. Whereas somatic hypermutations or VDJ rearrangements are required to acquire L452-contacting hydrophobic residues for non-IGHV1-69 encoded antibodies. Antibody repertoire analysis revealed that IGHV1-69 L452-contacting antibody lineages are commonly induced among COVID-19 convalescents but non-IGHV1-69 encoded antibodies exhibit limited prevalence. In addition, we experimentally demonstrated that L452R renders most published IGHV1-69 antibodies ineffective. Furthermore, we found that IGHV1-69 L452-contacting antibodies are enriched in convalescents experienced Omicron BA.1 (without L452R) breakthrough infections but rarely found in Delta (with L452R) breakthrough infections. Taken together, these findings support that IGHV1-69 population antibodies contribute to selection pressure for L452 substitution. This study thus provides a better understanding of SARS-CoV-2 variant genesis and immune evasion.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Emerging microbes & infections - 11(2022), 1 vom: 08. Dez., Seite 2749-2761

Sprache:

Englisch

Beteiligte Personen:

Yan, Qihong [VerfasserIn]
Hou, Ruitian [VerfasserIn]
Huang, Xiaohan [VerfasserIn]
Zhang, Yanjun [VerfasserIn]
He, Ping [VerfasserIn]
Zhang, Yudi [VerfasserIn]
Liu, Banghui [VerfasserIn]
Wang, Qian [VerfasserIn]
Rao, Haiyue [VerfasserIn]
Chen, Xianying [VerfasserIn]
Zhao, Xinwei [VerfasserIn]
Niu, Xuefeng [VerfasserIn]
Zhao, Jincun [VerfasserIn]
Xiong, Xiaoli [VerfasserIn]
Chen, Ling [VerfasserIn]

Links:

Volltext

Themen:

Antibodies, Neutralizing
Antibodies, Viral
IGHV1-69
Immune evasion
Journal Article
L452R
SARS-CoV-2
Shared antibody response
Spike Glycoprotein, Coronavirus
Spike protein, SARS-CoV-2

Anmerkungen:

Date Completed 15.11.2022

Date Revised 16.11.2022

published: Print

Citation Status MEDLINE

doi:

10.1080/22221751.2022.2140611

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM348025351